Novo Nordisk
NVO
#61
Rank
S$320.53 B
Marketcap
S$62.45
Share price
3.63%
Change (1 day)
-44.27%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): S$26.82 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are S$47.70 Billion. , an increase over its 2024 earnings that were of S$23.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 S$26.12 B9.13%
2024 S$23.94 B22.84%
2023 S$19.48 B57.81%
2022 S$12.35 B5.24%
2021 S$11.73 B12.38%
2020 S$10.44 B13.11%
2019 S$9.23 B-3.45%
2018 S$9.56 B1.88%
2017 S$9.38 B4.3%
2016 S$8.99 B10.32%
2015 S$8.15 B7.47%
2014 S$7.58 B3.4%
2013 S$7.34 B19.09%
2012 S$6.16 B15.58%
2011 S$5.33 B16.58%
2010 S$4.57 B25.66%
2009 S$3.64 B10.68%
2008 S$3.28 B55.82%
2007 S$2.11 B7.02%
2006 S$1.97 B19.05%
2005 S$1.65 B10.55%
2004 S$1.49 B
2002 S$1.05 B-14.39%
2001 S$1.22 B-52.82%
2000 S$2.60 B250%
1999 S$0.74 B31.21%
1998 S$0.56 B34.31%
1997 S$0.42 B11.46%
1996 S$0.37 B9.03%
1995 S$0.34 B-3.15%
1994 S$0.35 B-0.67%
1993 S$0.36 B45.38%
1992 S$0.24 B-13.81%
1991 S$0.28 B37.12%
1990 S$0.20 B-0.79%
1989 S$0.21 B26.2%
1988 S$0.16 B24.97%
1987 S$0.13 B-0.9%
1986 S$0.13 B-7.78%
1985 S$0.14 B24.87%
1984 S$0.11 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$14.99 B-42.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.46 B 8.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.51 B-55.94%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$10.16 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA